Genetic engineering of stem cells for enhanced therapy

Area of Science:

• Biotechnology
• Regenerative Medicine
• Genetic Engineering

Background:

• Stem cell therapy holds promise for treating diseases but requires stem cell modification for optimal efficacy.
• Genetic engineering offers precise control over gene expression, making it attractive for modifying stem cell properties.

Purpose of the Study:

• To review current genetic engineering strategies for stem cell modification.
• To compare virus-based and non-viral methods for inducing transient and permanent transgene expression.
• To discuss the implications for clinical applications of engineered stem cells.

Main Methods:

• Exploration of virus-based genetic manipulation (integrating and non-integrating vectors).
• Overview of non-viral methods for nucleic acid delivery and transfection.
• Analysis of transient versus permanent transgene expression strategies.

Main Results:

• Viral vectors achieve efficient, long-term expression but pose safety risks.
• Non-integrating viruses offer high efficiency and safety but limited expression duration.
• mRNA-based methods provide rapid, safe, and efficient transient gene expression suitable for specific applications.

Conclusions:

• Stem cell engineering for clinical use is emerging and requires further research.
• Transient expression via mRNA is optimal for applications like stem cell trafficking and short-term therapies.
• Development of safe, non-viral methods for permanent transgene expression (e.g., transposons, artificial chromosomes) is crucial.